Xampla closed a £6.2 million seed finance round led by Horizons Ventures
Xampla, a Cambridge, UK-based producer of natural plant-protein alternatives for microplastics and single-use plastics, announced the completion of a funding round of £6.2 million ($8.4M).
The money was raised from investors led by Horizons Ventures, who join existing shareholders Amadeus Capital Partners, Cambridge Enterprise, and the impact investment fund Sky Ocean Ventures. The latter invested in the company in a £2 million round announced in April 2020.
Xampla, founded in 2018 as a spin-out from the University of Cambridge by CEO Simon Hombersley, develops the world’s first plant protein-based replacement for microplastics added to everyday items.
The creation of the new material stems from a breakthrough from protein experts Professor Tuomas Knowles and Dr Marc Rodriguez-Garcia, inspired by the process a spider uses to create silk. Xampla facilitates a similar transformation at scale and in a very efficient process by using widely-available and renewable plant proteins, without the need for harmful solvents. The resulting Supramolecular Engineered Protein can be structured into plastic-like materials such as films, gels and capsules. Xampla holds two patents for the new material, with a third in development.